SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-042199
Filing Date
2020-09-01
Accepted
2020-09-01 16:14:39
Documents
16
Period of Report
2020-08-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K odt-8k_20200827.htm   iXBRL 8-K 38638
2 EX-1.1 odt-ex11_6.htm EX-1.1 191597
3 EX-5.1 odt-ex51_7.htm EX-5.1 7400
4 GRAPHIC gd4gd3krqurz000002.jpg GRAPHIC 30438
5 GRAPHIC gd4gd3krqurz000001.jpg GRAPHIC 89690
  Complete submission text file 0001564590-20-042199.txt   586039

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA odt-20200827.xsd EX-101.SCH 5769
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE odt-20200827_lab.xml EX-101.LAB 20210
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE odt-20200827_pre.xml EX-101.PRE 12079
9 EXTRACTED XBRL INSTANCE DOCUMENT odt-8k_20200827_htm.xml XML 3685
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38318 | Film No.: 201154600
SIC: 2834 Pharmaceutical Preparations